Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis
The use of ticagrelor is associated with significantly higher rates of bleeding when compared with clopidogrel in patients with concomitant atrial fibrillation and coronary artery disease.
Authors
- Jing Gong (ORCID: https://orcid.org/0000-0001-8423-3706)
- Naifeng Liu
- Yang Li
Institutions
- Zhongda Hospital Southeast University (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/tcrm.s575007
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China